Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/16937526

World J. Gastroenterol. 2006 Aug 28 12 32 5160-7

Download in:

View as

General Info

PMID
16937526